Page 15 - Read Online
P. 15

Tsuboi et al. Mini-invasive Surg 2024;8:26  https://dx.doi.org/10.20517/2574-1225.2023.94  Page 9 of 21

               to 4 L of liquid laxatives such as PEG solution. In a recent meta-analysis, PEG laxative and sodium
               phosphate (NaP) boosters were the most commonly used regimens. However, this regimen was not
                                                                                   [100]
               associated with a higher complete examination rate or bowel cleansing level . Another meta-analysis
               reported that routine prokinetics specifications and split-dose PEG were associated with complete
               examinations . Ohmiya et al. reported the effectiveness of castor oil as a booster of CCE . They reported
                                                                                          [102]
                          [101]
               that the capsule excretion rate of castor oil was significantly higher than that without castor oil (97% and
               81%, respectively; P < 0.0001). In a recent meta-analysis, the castor oil has the potential for improvement of
               excretion rates in CCE . To address these issues, the Japanese Association for Capsule Endoscopy (JACE)
                                  [103]
               recommends castor oil as the standard preparation regimen for CCE. Mizukami et al. reported that
               encapsulation of castor oil increased patient tolerability while maintaining the capsule excretion rate .
                                                                                                      [104]
               However, patient acceptance is poor because of the unpleasant flavor of castor oil. On the other hand, for
               patients with ulcerative colitis, the same rigorous preparation required for colorectal tumors is not necessary
                                                                                                       [88]
               to observe mucosal inflammation. Okabayashi et al. reported that a reduced dose of laxatives is possible .
               In fact, in JACE, the recommended regimens are separated for patients with ulcerative colitis and colorectal
               tumors.

               We summarized the current issues for SBCE and CCE in Table 1.


               CURRENT STATUS OF ECE
               ECE was developed as a non-invasive diagnostic tool based on SBCE technology, aimed at visualizing the
               esophagus without the need for sedation or invasive procedures associated with traditional endoscopy. The
               first generation of esophageal capsules, such as the PillCam ESO (Given Imaging Ltd., Yoqneam, Israel),
               was approved in 2004. The second generation of ECE, which has been improved and available since 2007,
                                                                                  TM
               shares a similar size, shape, and weight with the small-bowel capsule (PillCam  SB2), measuring 26 mm ×
               11 mm. It is equipped with cameras on both ends that capture images at 18 FPS, compared to the 2-3 FPS of
                                                                                                  TM
               small-bowel capsules, providing a wider 169° angle of view. The third-generation ECE, PillCam  ESO3,
               features an even wider 174° angle of view and a higher recording rate of 35 FPS.

               ECE was designed specifically to evaluate esophageal conditions, including gastroesophageal reflux disease
               (GERD), Barrett’s esophagus (BE), and esophageal varices. ECE operates by capturing high-speed images of
               the esophagus as the capsule travels through the gastrointestinal tract, offering a patient-friendly alternative
               to standard endoscopic examinations. Currently, ECE is primarily used for screening and monitoring
               esophageal varices, BE, and detecting other esophageal lesions in patients who are at high risk or unwilling
               to undergo conventional endoscopy. A meta-analysis conducted by Bhardwaj et al. revealed that the pooled
               sensitivity and specificity for the diagnosis of BE for all studies were 77% and 86%, respectively .
                                                                                                       [105]
               According to a recent meta-analysis by McCarty et al., the diagnostic pooled sensitivity and specificity for
               esophageal varices were 83% and 85%, respectively . In a multicenter prospective ECE study for pediatric
                                                          [106]
               patients by Cardey et al., the sensitivity, specificity, and accuracy for esophageal varices using a modified
               classification were 100 %, 93 %, and 97 %, respectively . ECE is a well-tolerated and safe procedure,
                                                                [107]
               making it a viable alternative to EGD in infants suspected of having esophageal varices or in cases where
               EGD is declined, such as pediatric patients.


               Recent improvements, such as the ability to transmit images in real-time, have enabled more immediate
               interpretation, facilitating quicker clinical decision-making. Despite its advantages, ECE faces challenges,
               including limited maneuverability compared to conventional endoscopes, the potential for incomplete
               examinations due to rapid transit times, and the need for further validation in detecting early-stage
               neoplasms. Additionally, image interpretation requires significant expertise, highlighting the need for
   10   11   12   13   14   15   16   17   18   19   20